Current filters:


Popular Filters

6654 to 6678 of 7024 results

AstraZeneca’s thyroid cancer drug Caprelsa gets positive CHMP opinion


Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that its Marketing Authorization…


GlaxoSmithKline’s albiglutide fails to show superiority over Novo Nordisk’s Victoza


UK pharma giant GlaxoSmithKline (LSE: GSK) released disappointing top-line results from the first of…

albiglutideDiabetesGlaxoSmithKlineNovo NordiskPharmaceuticalResearchVictoza

Newron says it has received interest in safinamide, rejected by Merck Serono


Following the announcement of Switzerland-based Newron Pharmaceuticals (SIX: NWRN) regaining the global…

LicensingNeurologicalNewron PharmaPharmaceuticalsafinamide

EU Commission unveils 12 concrete actions against antimicrobial resistance for the next five years


With about 25,000 patients dying per year in the European Union from infections caused by drug resistant…

Antibiotics and Infectious diseasesEuropePharmaceuticalRegulationResearch

Stakeholders deliberate accessibility, debate whether pricing hinders access to health care in India


To address the burgeoning concern about the need to ensure health care access in India, ASSOCHAM organized…


Brand drug 'Co-pay Coupons' undermine generics, raise health costs by $1.1 billion in US state of Michigan


The proliferation of brand drug "co-pay coupon" promotions, which lure insured consumers from generics…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalPricing

Hormone that controls iron levels may be target for atherosclerosis treatment, researchers find


Researchers at Emory University School of Medicine, USA, have identified hepcidin, a hormone that regulates…


UK’s NICE rejects Eisai’s Halaven for advanced breast cancer


In a second negative from the UK’s National Institute for Health and Clinical Excellence, in final…


Indian vaccine market targets $4.6 billion revenue by 2017, up from current $900 million


The Indian vaccine market is currently estimated to be worth around $900 million and targets $4.6 billion…

Asia-PacificMarkets & MarketingPharmaceuticalResearchVaccines

Boehringer Ingelheim invests over $350 million in 2011 US expansion projects


Privately-held German drug major Boehringer Ingelheim says that it has made more than $350 million worth…

Boehringer IngelheimFinancialNorth AmericaPharmaceuticalResearch

Health organizations in USA will act despite political and economic uncertainty, PwC survey finds


In its annual report on the top health industry issues for the year ahead, PwC's Health Research Institute…

HealthcareNorth AmericaPharmaceuticalRegulationResearch

Premier report “inaccurate in reporting drug price profit margins of small distributors” in USA, says Pharma Commerce


A report by Premier healthcare alliance incorrectly calculated the percent markup charged by small distributors…

North AmericaPharmaceuticalPricing

Italy’s Menarini takes giant step into Asia-Pacific, with acquisition of Invida


Italy’s leading independent drugmaker Menarini says it has acquired the Singapore-based Invida Group,…

Asia-PacificInvidaMenariniMergers & AcquisitionsPharmaceutical

New legislative amendments may result in huge losses for global pharma producers in Russia


Sergei Lisovsky, a well-known Russian senator and public figure, has put forward an initiative to make…


Bayer plans further capital spending of 1.8 billion euros in Asia


German pharma, crop and material sciences group Bayer (BAY: DE) this morning disclosed plans to further…

Asia-PacificBayerFinancialMarkets & MarketingPharmaceutical

Mixed results for AstraZeneca in study comparing Crestor with Lipitor


Anglo-Swedish drug major AstraZeneca (LSE: AZN) presented mixed results from a study comparing its cholesterol…


Galenica acquires Spanish JV Vifor Uriach and Grupo Uriach's primary care business


Swiss drugmaker Galenica (SIX: GALN) has acquired all the outstanding shares of Vifor Uriach Pharma SL,…

GalenicaMergers & AcquisitionsPharmaceuticalUriach

Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million


UK specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) says it has disposed of the epilepsy drug Mysoline…

Laboratoires SERBMergers & AcquisitionsMysolineNeurologicalPharmaceuticalSinclair IS Pharma

Increase in US drug recalls and warning caused by manufacturing errors and regulatory non-compliance issues, says GBI


The numbers of warning letters and drug recalls issued by and reported to the US Food and Drug Administration…

BiotechnologyNorth AmericaPharmaceuticalRegulation

6654 to 6678 of 7024 results

Company Spotlight



Back to top